ID: ALA2289054

Max Phase: Preclinical

Molecular Formula: C23H19N3O3S

Molecular Weight: 417.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccc(OC)c1C(=O)Nc1nnc(-c2ccc(-c3ccccc3)cc2)s1

Standard InChI:  InChI=1S/C23H19N3O3S/c1-28-18-9-6-10-19(29-2)20(18)21(27)24-23-26-25-22(30-23)17-13-11-16(12-14-17)15-7-4-3-5-8-15/h3-14H,1-2H3,(H,24,26,27)

Standard InChI Key:  AJPJPVIPTQYYDT-UHFFFAOYSA-N

Associated Targets(non-human)

Chilo suppressalis 440 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 417.49Molecular Weight (Monoisotopic): 417.1147AlogP: 5.14#Rotatable Bonds: 6
Polar Surface Area: 73.34Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.73CX Basic pKa: CX LogP: 4.88CX LogD: 4.72
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.47Np Likeness Score: -1.31

References

1. NAKAGAWA Y, NISHIMURA K, IZUMI K, KINOSHITA K, KIMURA T, KURIHARA N, FUJITA T.  (1996)  Quantitative Structure-Activity Relationships of Larvicidal N-[5-(Substituted phenyl)-1, 3, 4-thiadiazol-2-yl]-benzamides in the Inhibition of N-Acetylglucosamine Incorporation into a Cultured Integument System,  21  (2): [10.1584/jpestics.21.195]

Source